HK Stock MarketDetailed Quotes

WUXI BIO (02269)

Watchlist
  • 33.300
  • +0.320+0.97%
Trading May 7 09:48 CST
137.79BMarket Cap25.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

WUXI BIO (02269) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological drugs15.89B72.92%
XDC5.9B27.08%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological drugs15.89B72.92%
XDC5.9B27.08%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North America12.65B58.07%
Europe5.04B23.14%
China2.68B12.30%
Other parts of the world1.41B6.49%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.82%
Sample Name
Sample Code
 +4.82%
Sample Name
Sample Code
 +3.27%
4
SHANGHAI PECHEM
00338
+1.55%
5
SINOPEC CORP
00386
+0.21%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +66.53%
Sample Name
Sample Code
 +59.51%
Sample Name
Sample Code
 +43.93%
4
Emdoor Information
001314
+35.80%
5
Business-intelligence Of Oriental Nations Corporation
300166
+27.38%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -